NCT04265105View on ClinicalTrials.gov

Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 22, 2021

Primary Completion Date

January 18, 2023

Study Completion Date

January 18, 2023

Conditions
Asthma
Interventions
DRUG

fluticasone-vilanterol

LABA-ICS combination Inhaled Long acting Beta agonist and inhaled corticosteroid

DRUG

Standard Preparation

inhaled SABA or Inhaled corticosteroid

Trial Locations (1)

Unknown

RCSI Bahrain, Al Muharraq

All Listed Sponsors
lead

Royal College of Surgeons in Ireland - Medical University of Bahrain

OTHER

NCT04265105 - Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults | Biotech Hunter | Biotech Hunter